These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8319722)

  • 1. Complement activation in neonatal disease.
    Zilow EP
    Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
    Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
    Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
    Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S; Sakurabayashi I
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylatoxin and terminal complement complexes in red cell salvage.
    Bengtsson A; Lisander B
    Acta Anaesthesiol Scand; 1990 Jul; 34(5):339-41. PubMed ID: 2389647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
    Langlois PF; Gawryl MS
    Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal complement complexes and anaphylatoxins in septic and ischemic patients.
    Heideman M; Norder-Hansson B; Bengtson A; Mollnes TE
    Arch Surg; 1988 Feb; 123(2):188-92. PubMed ID: 3277584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin generation and distribution during in vitro LDL apheresis.
    Parusel M; Kadar JG; Borberg H
    Infusionsther Transfusionsmed; 1992 Oct; 19(5):245-8. PubMed ID: 1288769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis.
    Roxvall LI; Bengtson LA; Heideman JM
    Arch Surg; 1990 Jul; 125(7):918-21. PubMed ID: 2369318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered concentrations of terminal complement complexes, anaphylatoxins, and leukotrienes in the coronary sinus during cardiopulmonary bypass.
    Bengtson A; Millocco I; Heideman M; Berggren H
    J Cardiothorac Anesth; 1989 Jun; 3(3):305-10. PubMed ID: 2520655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in relation to development of preeclampsia.
    Haeger M; Unander M; Bengtsson A
    Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during liver transplantation.
    Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
    Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement split products and the pathogenesis of SLE.
    Abramson SB; Weissmann G
    Hosp Pract (Off Ed); 1988 Dec; 23(12):45-56. PubMed ID: 3142905
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.